Join to View Full Profile
450 Brookline AvenueDana-Farber Cancer InstituteBoston, MA 02215
Phone+1 617-632-3360
Fax+1 617-632-2260
Dr. Griffin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1979 - 1980- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1976 - 1977
Johns Hopkins UniversityResidency, Internal Medicine, 1974 - 1976
Harvard Medical SchoolClass of 1974
Certifications & Licensure
MA State Medical License 1975 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1989
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs.Wei Ni, Swati Garg, Basudev Chowdhury, Martin Sattler, Dana Sanchez
Molecular Therapy. Oncology. 2025-03-20 - BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation.Swati Garg, Wei Ni, Basudev Chowdhury, Ellen L Weisberg, Martin Sattler
Cell Death and Differentiation. 2024-07-01 - Author Correction: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.Douglas W McMillin, Jake Delmore, Ellen Weisberg, Joseph M Negri, Corey D Geer
Nature Medicine. 2024-04-01
Press Mentions
'World First' For Double Hand Transplant PatientMay 10th, 2024
RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory BoardApril 25th, 2017
TFS Appoints Dr. Bassem Saleh as Chief Medical Officer and Mr. Edward (Ed) Tumaian as VP Global Clinical DevelopmentMarch 22nd, 2017- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
